IT1190361B - Composizione farmaceutica in crema per uso dermale ed oftalmico - Google Patents

Composizione farmaceutica in crema per uso dermale ed oftalmico

Info

Publication number: IT1190361B
Authority: IT; Italy
Prior art keywords: cream; dermal; pharmaceutical composition; ophthalmic use; active ingredient
Prior art date: 1985-05-30

Application number

IT20970/85A

Other languages

English (en)

Other versions

IT8520970A0 (it

Inventor

Annibale Gazzaniga

Federico Stroppolo

Valter Gianesello

Original Assignee

Zambon Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-05-30

Filing date

1985-05-30

Publication date

1988-02-16

1985-05-30 Application filed by Zambon Spa filed Critical Zambon Spa

1985-05-30 Priority to IT20970/85A priority Critical patent/IT1190361B/it

1985-05-30 Publication of IT8520970A0 publication Critical patent/IT8520970A0/it

1986-05-29 Priority to JP61125583A priority patent/JPH0764745B2/ja

1986-05-30 Priority to AT86107343T priority patent/ATE43244T1/de

1986-05-30 Priority to DE8686107343T priority patent/DE3663449D1/de

1986-05-30 Priority to EP86107343A priority patent/EP0205051B1/en

1988-02-16 Application granted granted Critical

1988-02-16 Publication of IT1190361B publication Critical patent/IT1190361B/it

Links

230000002500 effect on skin Effects 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
102000009024 Epidermal Growth Factor Human genes 0.000 abstract 3
101800003838 Epidermal growth factor Proteins 0.000 abstract 3
229940116977 epidermal growth factor Drugs 0.000 abstract 3
VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 abstract 3
239000004480 active ingredient Substances 0.000 abstract 2
206010010984 Corneal abrasion Diseases 0.000 abstract 1
208000028006 Corneal injury Diseases 0.000 abstract 1
201000007717 corneal ulcer Diseases 0.000 abstract 1
239000006071 cream Substances 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1
239000003755 preservative agent Substances 0.000 abstract 1
239000008213 purified water Substances 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1
239000004094 surface-active agent Substances 0.000 abstract 1
231100000397 ulcer Toxicity 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1808—Epidermal growth factor [EGF] urogastrone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Dermatology (AREA)
Ophthalmology & Optometry (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

IT20970/85A 1985-05-30 1985-05-30 Composizione farmaceutica in crema per uso dermale ed oftalmico IT1190361B (it)

Priority Applications (5)

Application Number	Priority Date	Filing Date	Title
IT20970/85A IT1190361B (it)	1985-05-30	1985-05-30	Composizione farmaceutica in crema per uso dermale ed oftalmico
JP61125583A JPH0764745B2 (ja)	1985-05-30	1986-05-29	皮膚科ならびに眼科用の外傷、潰瘍治療用クリーム剤
AT86107343T ATE43244T1 (de)	1985-05-30	1986-05-30	Pharmazeutische zusammensetzung in form einer salbe zur dermischen und ophthalmischen verwendung.
DE8686107343T DE3663449D1 (en)	1985-05-30	1986-05-30	A pharmaceutical composition in the form of a cream for dermal and ophthalmic use
EP86107343A EP0205051B1 (en)	1985-05-30	1986-05-30	A pharmaceutical composition in the form of a cream for dermal and ophthalmic use

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT20970/85A IT1190361B (it)	1985-05-30	1985-05-30	Composizione farmaceutica in crema per uso dermale ed oftalmico

Publications (2)

Publication Number	Publication Date
IT8520970A0 IT8520970A0 (it)	1985-05-30
IT1190361B true IT1190361B (it)	1988-02-16

Family

ID=11174785

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IT20970/85A IT1190361B (it)	1985-05-30	1985-05-30	Composizione farmaceutica in crema per uso dermale ed oftalmico

Country Status (5)

Country	Link
EP (1)	EP0205051B1 (it)
JP (1)	JPH0764745B2 (it)
AT (1)	ATE43244T1 (it)
DE (1)	DE3663449D1 (it)
IT (1)	IT1190361B (it)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4837381A (en) *	1986-08-11	1989-06-06	American Cyanamid Company	Compositions for parenteral administration and their use
ATE74009T1 (de) *	1986-08-11	1992-04-15	American Cyanamid Co	Zusammensetzungen zur parenteralen verabreichung und deren verwendung.
WO1989001489A1 (en) *	1987-08-10	1989-02-23	Commonwealth Scientific And Industrial Research Or	Control of angiogenesis and compositions and methods therefor
US5705485A (en) *	1987-09-18	1998-01-06	Ethicon, Inc.	Gel formulations containing growth factors
US5032575A (en) *	1988-10-12	1991-07-16	Eye Research Institute Of Retina Foundation, Inc.	Method for enhancing healing of corneal endothelial wounds
US5036046A (en) *	1988-10-12	1991-07-30	Eye Research Institute Of Retina Foundation, Inc.	Method for enhancing healing of corneal endothelial wounds
US5051443A (en) *	1988-10-12	1991-09-24	Eye Research Institute Of Retina Foundation, Inc.	Method for enhancing healing of corneal endothelial wounds
JPH04305528A (ja) *	1991-02-22	1992-10-28	Dai Ichi Seiyaku Co Ltd	ケラチノサイト及び皮膚線維芽細胞の増殖刺激剤
ZA927277B (en) *	1991-10-02	1993-05-19	Boston Ocular Res	Dry eye treatment process and solution.
US5290920A (en) *	1992-04-16	1994-03-01	Allelix Biopharmaceuticals Inc.	Method of purifying human epidermal growth factor
FR2695556B1 (fr) *	1992-09-15	1995-03-24	Rochas Sa Parfums	Composition biologique contenant des EGF destinée à réguler la croissance cellulaire.
FR2695557A1 (fr) *	1992-09-15	1994-03-18	Rochas Sa Parfums	Composition biologique contenant des EGF destinée à réguler la croissance cellulaire.
KR100366439B1 (ko) *	2000-02-21	2003-01-09	주식회사 대웅	상피세포 성장인자를 유효성분으로 하는 안정한 약제학적조성물
KR102114993B1 (ko) *	2015-10-15	2020-05-25	주식회사 파이안에스테틱스	폴리펩타이드 및/또는 세포 배양 여액을 함유하는 수용성 스크럽 입자를 포함하는 화장제 조성물
CN110652493A (zh) *	2019-10-31	2020-01-07	福建蓝昊肽生物科技发展有限公司	一种增加生物活性肽乳膏稳定性的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3380839D1 (en) *	1983-11-02	1989-12-21	J C R Kabushiki Kaisha Also Kn	Ophthalmic preparations
JPS615006A (ja) *	1984-06-19	1986-01-10	Sanki Shoji Kk	皮膚用剤

1985
- 1985-05-30 IT IT20970/85A patent/IT1190361B/it active
1986
- 1986-05-29 JP JP61125583A patent/JPH0764745B2/ja not_active Expired - Lifetime
- 1986-05-30 AT AT86107343T patent/ATE43244T1/de not_active IP Right Cessation
- 1986-05-30 DE DE8686107343T patent/DE3663449D1/de not_active Expired
- 1986-05-30 EP EP86107343A patent/EP0205051B1/en not_active Expired

Also Published As

Publication number	Publication date
JPH0764745B2 (ja)	1995-07-12
DE3663449D1 (en)	1989-06-29
EP0205051A1 (en)	1986-12-17
IT8520970A0 (it)	1985-05-30
JPS6227A (ja)	1987-01-06
ATE43244T1 (de)	1989-06-15
EP0205051B1 (en)	1989-05-24

Similar Documents

Publication	Publication Date	Title
IT1190361B (it)	1988-02-16	Composizione farmaceutica in crema per uso dermale ed oftalmico
AU3232789A (en)	1989-10-05	Anesthetic skin moisturizing composition and method of preparing same
IL103920A (en)	2000-07-26	Pharmaceutical preparations for inhibiting the growth of cancer cells and use of lycopene for the preparation thereof
ES2153385T3 (es)	2001-03-01	Composicion acuosa a base de hormona del crecimiento humana.
ES554967A0 (es)	1987-12-16	Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido.
ZA885192B (en)	1989-04-26	Pharmaceutical preparations
DK0582239T3 (da)	1999-12-06	Farmaceutisk og/eller kosmetisk formulering
ATE55695T1 (de)	1990-09-15	Verwendung von defibrotid zur herstellung pharmazeutischer zusammensetzungen zur behandlung peripherer arteriopathien.
ES2194055T3 (es)	2003-11-16	Nuevo uso de prostaglandinas.
CA2135346A1 (en)	1995-05-10	Natural mixture composed of higher primary aliphatic alcohols obtained from bee wax for the treatment of gastric and duodenal ulcers that also presents antiinflamatory activity
IT1240683B (it)	1993-12-17	Composizione farmaceutica contenente egf
SE8703210D0 (sv)	1987-08-19	Hudvardskompositioner med keratolytisk och antiinflammatorisk aktivitet
AU624079B2 (en)	1992-06-04	Novel fluorinated derivatives of amino acids usable more particularly as surfactants or cosurfactants and preparations for biomedical use incorporating these derivatives
AU629445B2 (en)	1992-10-01	Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol
EP0265042A3 (en)	1990-01-31	Ophthalmic compositions comprising a tetraalkyl pyrazine
FR2616325B1 (fr)	1990-11-09	Composition contenant de l'hydroquinone et de l'acide kojique et composition pharmaceutique, notamment dermatologique, a activite depigmentante ou anti-inflammatoire, ou cosmetique comprenant de l'acide kojique et de l'hydroquinone
NO892495D0 (no)	1989-06-15	Fremgangsmaate for fremstilling av farmasoeytiske preparat.
IT8521528A0 (it)	1985-07-11	Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo diidrossi-1,8fenil-10 antrone-9, e procedimentodi preparazione dell'ingrediente attivo.
SE8705035L (sv)	1989-06-18	Anvaendning av alkylglycerol
FR2392674A1 (fr)	1978-12-29	Compositions pharmaceutiques a base d'elastine
DE3665403D1 (en)	1989-10-12	Pharmaceutical composition for topical application
AU591748B2 (en)	1989-12-14	Hair care compositions
IT1233426B (it)	1992-03-31	Composizioni farmaceutiche per uso orale ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo, e procedimento per prepararle
DE3573724D1 (en)	1989-11-23	Use of 1,8,9-triacetoxy-anthracene as the active ingredient in the preparation of an antitumoral pharmaceutical compound